SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Shekelle PG, MacLean CH, Morton SC, Wenger NS. Acove quality indicators. Ann Intern Med 2001; 135: 65367.
  • 2
    Naugler CT, Brymer C, Stolee P, Arcese ZA. Development and validation of an Improving Prescribing in the Elderly Tool. Can J Clin Pharmacol 2000; 7: 1037.
  • 3
    Hanlon JT, Schmader KE, Samsa GP, Weinberger M, Uttech KM, Lewis IK, Cohen HJ, Feussner JR. A method for assessing drug therapy appropriateness. J Clin Epidemiol 1992; 45: 104551.
  • 4
    Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003; 163: 271624.
  • 5
    Gallagher P, Ryan C, Byrne S, Kennedy J, O'Mahony D. STOPP screening tool of older person's prescriptions) and START (screening tool to alert doctors to right treatment). Consensus validation. Int J Clin Pharmacol Ther 2008; 46: 7283.
  • 6
    Laroche M, Charmes J, Bouthier F, Merle L. Inappropriate medications in the elderly. Clin Pharmacol Ther 2009; 85: 947.
  • 7
    Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 1991; 151: 182532.
  • 8
    Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 1997; 157: 15316.
  • 9
    Ay P, Akici A, Harmanc H. Drug utilization and potentially inappropriate drug use in elderly residents of a community in Istanbul, Turkey. Int J Clin Pharmacol Ther 2005; 43: 195202.
  • 10
    Rajska-Neumann A, Wieczorowska-Tobis K. Polypharmacy and potential inappropriateness of pharmacological treatment among community-dwelling elderly patients. Arch Gerontol Geriatr 2007; 44: 3039.
  • 11
    Pitkala KH, Strandberg TE, Tilvis RS. Inappropriate drug prescribing in home-dwelling, elderly patients: a population-based survey. Arch Intern Med 2002; 162: 170712.
  • 12
    Van Der Hooft CS, Jong GW, Dieleman JP, Verhamme KM, Van Der Cammen TJ, Stricker BH, Sturkenboom MC. Inappropriate drug prescribing in older adults: the updated 2002 Beers criteria – a population-based cohort study. Br J Clin Pharmacol 2005; 60: 13744.
  • 13
    De Oliveira Martins S, Soares MA, Foppe van Mil JW, Cabrita J. Inappropriate drug use by Portuguese elderly outpatients – effect of the Beers criteria update. Pharm World Sci 2006; 28: 296301.
  • 14
    De Wilde S, Carey IM, Harris T, Richards N, Victor C, Hilton SR, Cook DG. Trends in potentially inappropriate prescribing amongst older UK primary care patients. Pharmacoepidemiol Drug Saf 2007; 16: 65867.
  • 15
    Zhan C, Sangl J, Bierman AS, Miller MR, Friedman B, Wickizer SW, Meyer GS. Potentially inappropriate medication use in the community-dwelling elderly: findings from the 1996 Medical Expenditure Panel Survey. JAMA 2001; 286: 28239.
  • 16
    Willcox SM, Himmelstein DU, Woolhandler S. Inappropriate drug prescribing for the community-dwelling elderly. JAMA 1994; 272: 2926.
  • 17
    Simon SR, Chan KA, Soumerai SB, Wagner AK, Andrade SE, Feldstein AC, Lafata JE, Davis RL, Gurwitz JH. Potentially inappropriate medication use by elderly persons in U.S. Health Maintenance Organizations 2000–2001. J Am Geriatr Soc 2005; 53: 22732.
  • 18
    National Institute for Health and Clinical Excellence. Management of Hypertension in Adults in Primary Care. London: June 2006. Available at http://www.nice.org.uk/Guidance/CG34 (last accessed 5 August 2009).
  • 19
    O'Mahony D, Gallagher PF. Inappropriate prescribing in the older population: need for new criteria. Age Ageing 2008; 37: 13841.
  • 20
    Barry PJ, O'Keeffe N, O'Connor KA, O'Mahony D. Inappropriate prescribing in the elderly: a comparison of the Beers criteria and the improved prescribing in the elderly tool (IPET) in acutely ill elderly hospitalized patients. J Clin Pharm Ther 2006; 31: 61726.
  • 21
    Gallagher P, O'Mahony D. STOPP Screening Tool of Older Persons' potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria. Age Ageing 2008; 37: 6739.
  • 22
    Barry PJ, Gallagher P, Ryan C, O'Mahony D. START screening tool to alert doctors to the right treatment) – an evidence-based screening tool to detect prescribing omissions in elderly patients. Age Ageing 2007; 36: 6328.
  • 23
    Liu GG, Christensen DB. The continuing challenge of inappropriate prescribing in the elderly: an update of the evidence. J Am Pharm Assoc 2002; 42: 84757.
  • 24
    Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 37383.
  • 25
    Goldstein LB, Samsa GP, Matchar DB, Horner RD. Charlson Index comorbidity adjustment for ischemic stroke outcome studies. Stroke 2004; 35: 19415.
  • 26
    Rius C, Perez G, Martinez JM, Bares M, Schiaffino A, Gispert R, Fernandez E. An adaptation of Charlson comorbidity index predicted subsequent mortality in a health survey. J Clin Epidemiol 2004; 57: 4038.
  • 27
    World Health Organisation (WHO) collaborating centre for drug statistics methodology. ATC classification Index with DDDs. 2008.
  • 28
    Onder G, Pedone C, Landi F, Cesari M, Della Vedova C, Bernabei R, Gambassi G. Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc 2002; 50: 19628.
  • 29
    Winterstein AG, Sauer BC, Hepler CD, Poole C. Preventable drug-related hospital admissions. Ann Pharmacother 2002; 36: 123848.
  • 30
    Gallagher P, O'Mahony D. Inappropriate prescribing in older people. Rev Clin Gerontol 2008; 12: 6576.
  • 31
    Martin J, ed. British National Formulary, 55th edn. London: BMA/RPSGB, 2008.
  • 32
    Intercollegiate Stroke Working Party. National Clinical Guideline for Stroke, 3rd edn. London: Royal College of Physicians Clinical Effectiveness & Evaluation Unit, Royal College of Physicians, 2008; 678.
  • 33
    Sivenius J, Cunha L, Diener HC, Forbes C, Laakso M, Smets P, Riekkinen P. Second European Stroke Prevention Study: antiplatelet therapy is effective regardless of age. ESPS2 Working Group. Acta Neurol Scand 1999; 99: 5460.
  • 34
    McGowan B, Bennett K, Tilson L, Barry M. Cost effective prescribing of proton pump inhibitors (PPI's) in the GMS scheme. Ir Med J 2005; 98: 7880.
  • 35
    Wang PS, Bohn RL, Glynn RJ, Mogun H, Avorn J. Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture. Am J Psychiatry 2001; 158: 8928.
  • 36
    Pimlott NJ, Hux JE, Wilson LM, Kahan M, Li C, Rosser WW. Educating physicians to reduce benzodiazepine use by elderly patients: a randomized controlled trial. CMAJ 2003; 168: 8359.
  • 37
    Parr JM, Kavanagh DJ, Cahill L, Mitchell G, Young RM. Effectiveness of current treatment approaches for benzodiazepine discontinuation: a meta-analysis. Addiction 2009; 104: 1324.
  • 38
    Kvan E, Pettersen KI, Landmark K, Reikvam A. Treatment with statins after acute myocardial infarction in patients > or =80 years: underuse despite general acceptance of drug therapy for secondary prevention. Pharmacoepidemiol Drug Saf 2006; 15: 2617.
  • 39
    Kuijpers MAJ, Van Marum RJ, Egberts ACG, Jansen PAF, the OLDY (Old people Drug & DYsregulations) Study Group. Relationship between polypharmacy and underprescribing. Br J Clin Pharmacol 2008; 65: 1303.
  • 40
    Department of Health. Pharmacy in England – Building on Strengths – Delivering the Future. London: Department of Health, 2008.
  • 41
    Department of Health. Medicines and Older People: Implementing Medicines Related Aspects of the National Service Framework for Older People. London: Department of Health, 2001.
  • 42
    Holland R, Lenaghan E, Harvey I, Smith R, Shepstone L, Lipp A, Christou M, Evans D, Hand D. Does home based medication review keep older people out of hospital? The HOMER randomised controlled trial. BMJ 2005; 330: 2937.
  • 43
    Zermansky AG, Petty DR, Raynor DK, Lowe CJ, Freemantle N, Vail A. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ 2001; 323: 13403.
  • 44
    Lenaghan E, Holland R, Brooks A. Home-based medication review in a high risk elderly population in primary care – the POLYMED randomised controlled trail. Age Aging 2007; 36: 2927.
  • 45
    Zermansky AG, Alldred DP, Petty DR, Raynor DK, Freemantle N, Eastaugh J, Bowie P. Clinical medication review by a pharmacist of elderly people living in care homes – randomised controlled trial. Age Aging 2006; 35: 58691.
  • 46
    Krska J, Cromarty JA, Arris F, Jamieson D, Hansford D, Duffus PRS, Downie G, Seymour DG. Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Aging 2001; 30: 20511.